# Gert Mayer

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gert-mayer-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,767 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 31 |
| i10-index | 56 |
| Last Known Institution | Innsbruck Medical University |
| OpenAlex ID | https://openalex.org/A5103228335 |
| ORCID iD | 0000-0003-4605-1789 |
| Works | 131 |

## Researcher papers

- [Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial](https://scholariq.org/papers/atrasentan-and-renal-events-in-patients-with-type-2-diabetes-and-chronic-kidney/)
- [Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe](https://scholariq.org/papers/results-from-the-era-edta-registry-indicate-a-high-mortality-due-to-covid-19-in/)
- [Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference](https://scholariq.org/papers/iron-management-in-chronic-kidney-disease-conclusions-from-a-kidney-disease/)
- [Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease](https://scholariq.org/papers/canagliflozin-reduces-inflammation-and-fibrosis-biomarkers-a-potential-mechanism/)
- [Association of the COVID-19 pandemic with Internet Search Volumes: A Google TrendsTM Analysis](https://scholariq.org/papers/association-of-the-covid-19-pandemic-with-internet-search-volumes-a-google/)
- [Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-by-sodium/)
- [Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease](https://scholariq.org/papers/identification-of-urinary-exosomal-noncoding-rnas-as-novel-biomarkers-in-chronic/)
- [Data Sharing Under the General Data Protection Regulation](https://scholariq.org/papers/data-sharing-under-the-general-data-protection-regulation/)
- [Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss](https://scholariq.org/papers/dickkopf-3-dkk3-in-urine-identifies-patients-with-short-term-risk-of-egfr-loss/)
- [Analysis from the EMPA-REG OUTCOME® trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics](https://scholariq.org/papers/analysis-from-the-empa-reg-outcome-trial-indicates-empagliflozin-may-assist-in/)
- [Treatment Strategies of Adult Primary Focal Segmental Glomerulosclerosis: A Systematic Review Focusing on the Last Two Decades](https://scholariq.org/papers/treatment-strategies-of-adult-primary-focal-segmental-glomerulosclerosis-a/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

## Researcher university

- [Innsbruck Medical University](https://scholariq.org/institutions/innsbruck-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.